Nivolumab plus radiotherapy with or without temozolomide in newly diagnosed glioblastoma: Results from exploratory phase I cohorts of CheckMate 143

por Omuro, Antonio, Reardon, David A, Sampson, John H, Baehring, Joachim, Sahebjam, Solmaz, Cloughesy, Timothy F, Chalamandaris, Alexandros-Georgios, Potter, Von, Butowski, Nicholas, Lim, Michael
Publicado 2022

Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trial

por Omuro, Antonio, Brandes, Alba A, Carpentier, Antoine F, Idbaih, Ahmed, Reardon, David A, Cloughesy, Timothy, Sumrall, Ashley, Baehring, Joachim, van den Bent, Martin, Bähr, Oliver, Lombardi, Giuseppe, Mulholland, Paul, Tabatabai, Ghazaleh, Lassen, Ulrik, Sepulveda, Juan Manuel, Khasraw, Mustafa, Vauleon, Elodie, Muragaki, Yoshihiro, Di Giacomo, Anna Maria, Butowski, Nicholas, Roth, Patrick, Qian, Xiaozhong, Fu, Alex Z, Liu, Yanfang, Potter, Von, Chalamandaris, Alexandros-Georgios, Tatsuoka, Kay, Lim, Michael, Weller, Michael
Publicado 2022